Effect of melatonin on intracranial pressure and brain edema following traumatic brain injury: Role of oxidative stresses

Archives of Medical Research

Volumn 44, Issue 4, 2013, Pages 251-258

  Dehghan, Fatemeh ^a   Khaksari Hadad, Mohammad ^b   Asadikram, Gholamreza ^b   Najafipour, Hamid ^b   Shahrokhi, Nader ^a  

^a KERMAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b KERMAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Brain edema; Intracranial pressure; Melatonin; Neurological outcomes

Indexed keywords

EVANS BLUE; GLUTATHIONE PEROXIDASE; MALONALDEHYDE; MELATONIN; SUPEROXIDE DISMUTASE;

ANIMAL EXPERIMENT; ARTICLE; BLOOD BRAIN BARRIER; BRAIN EDEMA; BRAIN WATER; CONTROLLED STUDY; ENZYME ACTIVITY; INTRACRANIAL HYPERTENSION; INTRACRANIAL PRESSURE; MALE; NONHUMAN; OUTCOME ASSESSMENT; OXIDATIVE STRESS; RAT; TRAUMATIC BRAIN INJURY;

EID: 84879731753     PISSN: 01884409     EISSN: 18735487     Source Type: Journal    
DOI: 10.1016/j.arcmed.2013.04.002     Document Type: Article

References (81)

1. Oliveira C.O., Ikuta N., Regner A. Outcome biomarkers following severe traumatic brain injury. Rev Bras Ter Intensiva 2008, 20:411-421.
2. Rogatsky G.G., Kamenir Y., Mayevsky A. Effect of hyperbaric oxygenation on intracranial pressure elevation rate in rats during the early phase of severe traumatic brain injury. Brain Res 2005, 1047:131-136.
3. Pugliese F., Ruberto F., Perrella S.M., et al. Modifications of intracranial pressure after molecular adsorbent recirculating system treatment in patients with acute liver failure: case reports. Transplant Proc 2007, 39:2042-2044.
4. King D.R., Cohn S.M., Proctor K.G. Changes in intracranial pressure, coagulation, and neurologic outcome after resuscitation from experimental traumatic brain injury with hetastarch. Surgery 2004, 136:355-363. (Oxford).
5. Avezaat C., Van Eijndhoven J., Wyper D. Cerebrospinal fluid pulse pressure and intracranial volume-pressure relationships. J Neurol Neurosurg Psychiatry 1979, 42:687-700.
6. Chieregato A., Tanfani A., Compagnone C., et al. Cerebral blood flow in traumatic contusions is predominantly reduced after an induced acute elevation of cerebral perfusion pressure. Neurosurgery 2007, 60:115-123.
7. Feickert H.J., Drommer S., Heyer R. Severe head injury in children: impact of risk factors on outcome. J Trauma 1999, 47:33.
8. Stahel P.F., Shohami E., Younis F.M., et al. Experimental closed head injury: analysis of neurological outcome, blood-brain barrier dysfunction, intracranial neutrophil infiltration, and neuronal cell death in mice deficient in genes for pro-inflammatory cytokines. J Cereb Blood Flow Metab 2000, 20:369-380.
9. Rowlands H.E., Morris K.P. Management of severe traumatic brain injury. Paediatr Child Health 2007, 17:82-88.
10. Engelborghs K., Verlooy J., Van Reempts J., et al. Temporal changes in intracranial pressure in a modified experimental model of closed head injury. J Neurosurg 1998, 89:796-806.
11. Jamali S., Bodjarian N., Vigue B., et al. Increase in the chronically monitored cerebrospinal fluid pressure after experimental brain injury in rats. Brain Inj 1998, 12:525-536.
12. Soustiel J.F., Larisch S. Mitochondrial damage: a target for new therapeutic horizons. Neurotherapeutics 2010, 7:13-21.
13. Shlosberg D., Benifla M., Kaufer D., et al. Blood-brain barrier breakdown as a therapeutic target in traumatic brain injury. Nat Rev Neurol 2010, 6:393-403.
14. Vink R., Nimmo A.J. Multifunctional drugs for head injury. Neurotherapeutics 2009, 6:28-42.
15. Griesbach G.S., Hovda D.A., Gomez-Pinilla F., et al. Voluntary exercise or amphetamine treatment, but not the combination, increases hippocampal brain-derived neurotrophic factor and synapsin I following cortical contusion injury in rats. Neuroscience 2008, 154:530-540.
16. Gürsory-Zdemir Y., Can A., Dalkara T. Reperfusion-induced oxidative/nitrative injury to neurovascular unit after focal cerebral ischemia. Stroke 2004, 35:1449-1453.
17. del Zoppo G.J. Stroke and neurovascular protection. N Engl J Med 2006, 354:553-555.
18. Lisa Hill C.G. Cerebral blood flow and intracranial pressure. Anaesthesia 2007, 30-35.
19. Gutierrez-Cuesta J., Sureda F.X., Romeu M., et al. Chronic administration of melatonin reduces cerebral injury biomarkers in SAMP8. J Pineal Res 2007, 42:394-402.
20. Bains M., Hall E.D. Antioxidant therapies in traumatic brain and spinal cord injury. Biochim Biophys Acta 2012, 1822:675-684.
21. Reiter R.J., Fuentes-Broto L., Paredes S.D., et al. Melatonin and the pathophysiology of cellular membranes. Marmara Pharmaceutical 2010, 14:1-9.
22. Mesenge C., Margaill I., Verrecchia C., et al. Protective effect of melatonin in a model of traumatic brain injury in mice. J Pineal Res 1998, 25:41-46.
23. Beni S.M., Kohen R., Reiter R.J., et al. Melatonin-induced neuroprotection after closed head injury is associated with increased brain antioxidants and attenuated late-phase activation of NF-ΰB and AP-1. FASEB J 2004, 18:149-151.
24. Sarrafzadeh A.S., Thomale U.W., Kroppenstedt S.N., et al. Neuroprotective effect of melatonin on cortical impact injury in the rat. Acta Neurochir (Wien) 2000, 142:1293-1299.
25. Chen H.Y., Chen T.Y., Lee M.Y., et al. Melatonin decreases neurovascular oxidative/nitrosative damage and protects against early increases in the blood-brain barrier permeability after transient focal cerebral ischemia in mice. J Pineal Res 2006, 41:175-182.
26. Maldonado M.D., Murillo-Cabezas F., Terron M.P., et al. The potential of melatonin in reducing morbidity-mortality after craniocerebral trauma. J Pineal Res 2007, 42:1-11.
27. Swarnakar S., Paul S., Singh L.P., et al. Matrix metalloproteinases in health and disease: regulation by melatonin. J Pineal Res 2011, 50:8-20.
28. Xiao F. Bench to bedside: brain edema and cerebral resuscitation: the present and future. Acad Emerg Med 2002, 9:933-946.
29. Kabadi S.V., Maher T.J. Posttreatment with uridine and melatonin following traumatic brain injury reduces edema in various brain regions in rats. Ann NY Acad Sci 2010, 1199:105-113.
30. Seifman M.A., Adamides A.A., Nguyen P.N., et al. Endogenous melatonin increases in cerebrospinal fluid of patients after severe traumatic brain injury and correlates with oxidative stress and metabolic disarray. J Cereb Blood Flow Metab 2008, 28:684-696.
31. Shekleton J., Parcell D., Redman J., et al. Sleep disturbance and melatonin levels following traumatic brain injury. Neurology 2010, 74:1732-1738.
32. Chern C.M., Liao J.F., Wang Y.H., et al. Melatonin ameliorates neural function by promoting endogenous neurogenesis through MT2 melatonin receptor in ischemic stroke mice. Free Radic Biol Med 2012, 52:1634-1647.
33. Chen T.Y., Lee M.Y., Chen H.Y., et al. Melatonin attenuates the postischemic increase in blood-brain barrier permeability and decreases hemorrhagic transformation of tissue-plasminogen activator therapy following ischemic stroke in mice. J Pineal Res 2006, 40:242-250.
34. Ozdemir D., Tugyan K., Uysal N., et al. Protective effect of melatonin against head trauma-induced hippocampal damage and spatial memory deficits in immature rats. Neurosci Lett 2005, 385:234-239.
35. Ozdemir D., Uysal N., Gonenc S., et al. Effect of melatonin on brain oxidative damage induced by traumatic brain injury in immature rats. Physiol Res 2005, 54:631.
36. Marmarou A., Foda M.A., van den Brink W., et al. A new model of diffuse brain injury in rats. J Neurosurg 1994, 80:291-300.
37. Shahrokhi N., Khaksari M., Soltani Z., et al. Effect of sex steroid hormones on brain edema, intracranial pressure, and neurologic outcomes after traumatic brain injury. Can J Physiol Pharmacol 2010, 88:414-421.
38. O'Connor C.A., Cernak I., Vink R. Both estrogen and progesterone attenuate edema formation following diffuse traumatic brain injury in rats. Brain Res 2005, 1062:171-174.
39. Yoshihiro T., Keiji K., Takahiko O., et al. Transcutaneous cisternal puncture for sampling of cerebral fluid in a weak rat. Exp Anim 2005, 54:193-196.
40. Rao B., Soufir J.C., Martin M., et al. Lipid peroxidation in human spermatozoa as related to midpiece abnormalities and motility. Gamete Res 1980, 24:127-134.
41. Kondoh T., Uneyama H., Nishino H., et al. Melatonin reduces cerebral edema formation caused by transient forebrain ischemia in rats. Life Sci 2002, 72:583-590.
42. Gorgulu A., Palaoglu S., Ismailoglu O., et al. Effect of melatonin on cerebral edema in rats. Neurosurgery 2001, 49:1434.
43. Li Z., Liang G., Xue Y., et al. Effects of combination treatment of dexamethasone and melatonin on brain injury in intracerebral hemorrhage model in rats. Brain Res 2009, 1264:98-103.
44. Toklu H., Deniz M., Yüksel M., et al. Original research: The protective effect of melatonin and amlodipine against cerebral ischemia/reperfusion-induced oxidative brain injury rats. Marmara Med J 2009, 22:34-44.
45. Kelso M.L., Scheff N.N., Scheff S.W., et al. Melatonin and minocycline for combinatorial therapy to improve functional and histopathological deficits following traumatic brain injury. Neurosci Lett 2011, 488:60-64.
46. Gasche Y., Copin J.C., Sugawara T., et al. Matrix metalloproteinase inhibition prevents oxidative stress-associated blood-brain barrier disruption after transient focal cerebral ischemia. J Cereb Blood Flow Metab 2001, 21:1393-1400.
47. Klussmann S., Martin-Villalba A. Molecular targets in spinal cord injury. J Mol Med (Berl) 2005, 83:657-671.
48. Hung Y.C., Chen T.Y., Lee E.J., et al. Melatonin decreases matrix metalloproteinase-9 activation and expression and attenuates reperfusion-induced hemorrhage following transient focal cerebral ischemia in rats. J Pineal Res 2008, 45:459-467.
49. Ganguly K., Swarnakar S. Induction of matrix metalloproteinase-9 and -3 in nonsteroidal anti-inflammatory drug-induced acute gastric ulcers in mice: regulation by melatonin. J Pineal Res 2009, 47:43-55.
50. Reiter R.J., Tan D., Manchester L.C., et al. Biochemical reactivity of melatonin with reactive oxygen and nitrogen species. Cell Biochem Biophys 2001, 34:237-256.
51. Turgut M., Erdogan S., Ergin K., et al. Melatonin ameliorates blood-brain barrier permeability, glutathione, and nitric oxide levels in the choroid plexus of the infantile rats with kaolin-induced hydrocephalus. Brain Res 2007, 1175:117-125.
52. Rooker S., Jorens P.G., Van Reempts J., et al. Continuous measurement of intracranial pressure in awake rats after experimental closed head injury. J Neurosci Methods 2003, 131:75-81.
53. Goren S., Kahveci N., Alkan T., et al. The effects of sevoflurane and isoflurane on intracranial pressure and cerebral perfusion pressure after diffuse brain injury in rats. J Neurosurg Anesthesiol 2001, 13:113.
54. Kahveci F.S., Kahveci N., Alkan T., et al. Propofol versus isoflurane anesthesia under hypothermic conditions: effects on intracranial pressure and local cerebral blood flow after diffuse traumatic brain injury in the rat. Surg Neurol 2001, 56:206-214.
55. Smith M. Monitoring intracranial pressure in traumatic brain injury. Anesth Analg 2008, 106:240-248.
56. Savaskan E., Hock C., Olivieri G., et al. Cortical alterations of angiotensin converting enzyme, angiotensin II and AT1 receptor in Alzheimer's dementia. Neurobiol Aging 2001, 22:541-546.
57. Dubocovich M.L., Markowska M. Functional MT 1 and MT 2 melatonin receptors in mammals. Endocrine 2005, 27:101-110.
58. Maslennikov D., Ganshina T.S., Mirzoyan R.S. Influence of melatonin on blood flow in cerebral cortex under conditions of global transient ischemia. Eur Neuropsychopharmacol 2011, 21:S127.
59. Gan'shina T.S., Mirzoian R.S. GABAergic mechanism of cerebrovascular effect of mexidol. Eksp Klin Farmakol 2010, 73:11.
60. Reiter R.J., Calvo J.R., Karbownik M., et al. Melatonin and its relation to the immune system and inflammation. Ann NY Acad Sci 2000, 917:376-386.
61. Marmarou A. A review of progress in understanding the pathophysiology and treatment of brain edema. Neurosurg Focus 2007, 22:E1.
62. Shahlaie K., Boggan J.E., Latchaw R.E., et al. Posttraumatic vasospasm detected by continuous brain tissue oxygen monitoring: treatment with intraarterial verapamil and balloon angioplasty. Neurocrit Care 2009, 10:61-69.
63. Jaeger M., Dengl M., Meixensberger J., et al. Effects of cerebrovascular pressure reactivity-guided optimization of cerebral perfusion pressure on brain tissue oxygenation after traumatic brain injury. Crit Care Med 2010, 38:1343.
64. Bayir H., Kagan V.E., Clark R.S.B., et al. Neuronal NOS-mediated nitration and inactivation of manganese superoxide dismutase in brain after experimental and human brain injury. J Neurochem 2007, 101:168-181.
65. Niles L.P., Armstrong K.J., Rincón Castro L.M., et al. Neural stem cells express melatonin receptors and neurotrophic factors: colocalization of the MT1 receptor with neuronal and glial markers. BMC Neurosci 2004, 5:41.
66. Ercan M., Inci S., Kilinc K., et al. Nimodipine attenuates lipid peroxidation during the acute phase of head trauma in rats. Neurosurg Rev 2001, 24:127-130.
67. Shahrokhi N., Haddad M.K., Joukar S., et al. Neuroprotective antioxidant effect of sex steroid hormones in traumatic brain injury. Pak JPharm Sci 2012, 25:219-225.
68. Hall E.D., Vaishnav R.A., Mustafa A.G. Antioxidant therapies for traumatic brain injury. Neurotherapeutics 2010, 7:51-61.
69. Faden A.I. TRH analog YM-14673 improves outcome following traumatic brain and spinal cord injury in rats: dose-response studies. Brain Res 1989, 486:228-235.
70. Ates O., Cayli S., Gurses I., et al. Effect of pinealectomy and melatonin replacement on morphological and biochemical recovery after traumatic brain injury. Int J Dev Neurosci 2006, 24:357-363.
71. Fujimoto T., Nakamura T., Ikeda T., et al. Potent protective effects of melatonin on experimental spinal cord injury. Spine 2000, 25:769.
72. Wakatsuki A., Okatani Y., Shinohara K., et al. Melatonin protects against ischemia/reperfusion-induced oxidative damage to mitochondria in fetal rat brain. J Pineal Res 2001, 31:167-172.
73. Kerman M., Cirak B., Ozguner M.F., et al. Does melatonin protect or treat brain damage from traumatic oxidative stress?. Exp Brain Res 2005, 163:406-410.
74. Erol F.S., Kaplan M., Tiftikci M., et al. Comparison of the effects of octreotide and melatonin in preventing nerve injury in rats with experimental spinal cord injury. J Clin Neurosci 2008, 15:784-790.
75. Meki A.R., Hussein A.A.A. Melatonin reduces oxidative stress induced by ochratoxin A in rat liver and kidney. Comp Biochem Physiol CToxicol Pharmacol 2001, 130:305-313.
76. Rodriguez C., Mayo J.C., Sainz R.M., et al. Regulation of antioxidant enzymes: a significant role for melatonin. J Clin Neurosci 2004, 36:1-9.
77. Tomas-Zapico C., Coto-Montes A. A proposed mechanism to explain the stimulatory effect of melatonin on antioxidative enzymes. J Pineal Res 2005, 39:99-104.
78. Aygün D., Kaplan S., Odaci E., et al. Toxicity of non-steroidal anti-inflammatory drugs: a review of melatonin and diclofenac sodium association. Histol Histopathol 2012, 27:417.
79. Cirak B., Rousan N., Kocak A., et al. Melatonin as a free radical scavenger in experimental head trauma. Pediatr Neurosurg 1999, 31:298-301.
80. Leon J., Acuña-Castroviejo D., Sainz R.M., et al. Melatonin and mitochondrial function. Life Sci 2004, 75:765-790.
81. Pieri C., Marra M., Moroni F., et al. Melatonin: a peroxyl radical scavenger more effective than vitamin E. Life Sci 1994, 55:PL271-PL276.